Guggenheim Maintains Buy on Exelixis, Raises Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Michael Schmidt has maintained a Buy rating on Exelixis (NASDAQ:EXEL) and raised the price target from $32 to $33.
October 30, 2024 | 7:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guggenheim has reaffirmed its Buy rating on Exelixis and increased the price target to $33, indicating positive sentiment and potential upside.
The reaffirmation of a Buy rating and an increase in the price target by a reputable analyst can boost investor confidence and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100